A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of (90)Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

BACKGROUND: Selective internal radiation therapy (SIRT) with yttrium-90 ((90)Y) resin microspheres is an established locoregional treatment option for unresectable hepatocellular carcinoma (HCC), which delivers a lethal dose of radiation to hepatic tumors, while sparing surrounding healthy tissue. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahvash, Armeen, Chartier, Steven, Turco, Mark, Habib, Paula, Griffith, Steven, Brown, Scott, Kappadath, S. Cheenu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962126/
https://www.ncbi.nlm.nih.gov/pubmed/35346070
http://dx.doi.org/10.1186/s12876-022-02204-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962126/
https://www.ncbi.nlm.nih.gov/pubmed/35346070
http://dx.doi.org/10.1186/s12876-022-02204-1

Ejemplares similares